Monomethyl Auristatin E Intermediate Purification via TBME
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The current method for preparing the monomethyl auristatin E intermediate, compound b, suffers from low purity and yield, along with the risk of explosion due to the oxidation of dioxane used in the process.
Innovation Solution
A new method involving the removal of impurities using an organic reagent under reduced pressure concentration is employed, which includes steps such as removing the amino protecting group from compound 1 using hydrochloric acid, followed by sequential addition of organic solvents and concentration under reduced pressure to achieve high purity and yield.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If dioxane is used as the organic reagent for removing impurities, then the purity of compound b can be improved, but the safety risk increases due to oxidation and explosion hazards
Solution Approach 1:
The patent replaces dioxane with tert-butyl methyl ether (TBME), a safer, more stable organic reagent that does not have oxidation and explosion hazards. TBME achieves the same purification function while eliminating the safety risks associated with dioxane, making it a superior disposable reagent for this application.
Solution Approach 2:
The patent creates a safer chemical environment by using tert-butyl methyl ether, which provides an inert atmosphere during the purification process. This reagent does not undergo oxidation reactions and is not prone to explosion, thereby creating a safe working environment that eliminates the harmful effects associated with dioxane.
2Manufacturing precision
If the conventional purification method is used, then the purity of compound b reaches 99.6%, but the yield is reduced to 82.3%
Solution Approach 1:
The patent changes the key parameter of the purification process by replacing dioxane with tert-butyl methyl ether. This parameter change optimizes the purification efficiency, achieving a remarkable improvement in yield (from 82.3% to 95%) while maintaining high purity (99%), thereby resolving the contradiction between purity and productivity.
Solution Approach 2:
The use of tert-butyl methyl ether as a disposable purification reagent provides superior performance compared to dioxane. It achieves both high purity and high yield in a single purification step, eliminating the need for multiple purification steps and thereby improving overall productivity without sacrificing manufacturing precision.
3Manufacturing precision
If multiple purification steps are performed to achieve high purity, then the purity of compound b is improved, but the production time and complexity increase
Solution Approach 1:
The patent uses tert-butyl methyl ether as a single-step purification reagent that achieves both high purity (99%) and high yield (95%) simultaneously. This eliminates the need for multiple sequential purification steps, thereby reducing production time and simplifying the purification process while maintaining manufacturing precision.
Solution Approach 2:
The patent merges the functions of multiple purification steps into a single purification operation using tert-butyl methyl ether. This consolidated approach achieves the same purification effect as multiple steps would provide, thereby reducing the total time required and simplifying the overall process without compromising purity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves a monomethyl auristatin E intermediate with high purity (up to 91% or more) and yield (as high as 95%), while significantly reducing the risk of explosions and improving the safety and cost-effectiveness of the production process.
Implementation Method 1
removing the amino protecting group R from compound 1 by hydrochloric acid method
Implementation Method 2
adding an appropriate amount of a first organic solvent to a reaction solution of step A, and concentrating under reduced pressure to obtain a concentrate a
Implementation Method 3
concentrating under reduced pressure
Data Source
AI summary
A method for preparing and purifying a monomethyl auristatin E intermediate. The method has the advantages of few steps, simple operation, cheap and easily available raw materials, high safety, a simple purification method and extremely high purity of a purified product, and the yield of the method can be as high as 95%, which not only improves the safety of the production process, but also significantly improves the yield of the product, and reduces the subsequent production cost. Therefore, the method is suitable for industrial popularization.